Cargando…

A comparative study of survival models for breast cancer prognostication revisited: the benefits of multi-gene models

BACKGROUND: The development of clinical -omic biomarkers for predicting patient prognosis has mostly focused on multi-gene models. However, several studies have described significant weaknesses of multi-gene biomarkers. Indeed, some high-profile reports have even indicated that multi-gene biomarkers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grzadkowski, Michal R., Sendorek, Dorota H., P’ng, Christine, Huang, Vincent, Boutros, Paul C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215649/ https://www.ncbi.nlm.nih.gov/pubmed/30390622 http://dx.doi.org/10.1186/s12859-018-2430-9

Ejemplares similares

Valection: design optimization for validation and verification studies
por: Cooper, Christopher I, et al.
Publicado: (2018)

Revisiting the multi-armed bandit model for the optimal design of clinical trials: benefits and drawbacks
por: Villar, Sofia S, et al.
Publicado: (2013)

Statins: benefits and risks revisited
por: Balaz, Miroslav, et al.
Publicado: (2019)

Revisiting methods for modeling longitudinal and survival data: Framingham Heart Study
por: Ngwa, Julius S., et al.
Publicado: (2021)

Benefits of biomarker selection and clinico-pathological covariate inclusion in breast cancer prognostic models
por: Parisi, Fabio, et al.
Publicado: (2010)

An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation
por: Candido dos Reis, Francisco J., et al.
Publicado: (2017)

The threshold model revisited
por: Djulbegovic, Benjamin, et al.
Publicado: (2018)

Gō model revisited
por: Takada, Shoji
Publicado: (2019)

Revisiting survival analysis
por: Sarmukaddam, Sanjeev
Publicado: (2011)

Elemental models of primate nursing and weaning revisited
por: Smith, Tanya M., et al.
Publicado: (2022)

Moorean tree snail survival revisited: a multi-island genealogical perspective
por: Lee, Taehwan, et al.
Publicado: (2009)

Prediction of early breast cancer patient survival using ensembles of hypoxia signatures
por: Gong, Inna Y., et al.
Publicado: (2018)

Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma
por: Chen, Jiajie, et al.
Publicado: (2023)

Model-based Recursive Partitioning for Survival of Iranian Female Breast Cancer Patients: Comparing with Parametric Survival Models
por: SAFE, Mozhgan, et al.
Publicado: (2017)

The hierarchical island model revisited
por: Vigouroux, Yves, et al.
Publicado: (2000)

Dynamic causal modelling revisited
por: Friston, K.J., et al.
Publicado: (2019)

New Care Models revisited
por: Thomas, Paul
Publicado: (2017)

Prognostic models in male breast cancer
por: van der Pol, Carmen C., et al.
Publicado: (2016)

Multi-chain Fudan-CCDC model for COVID-19—a revisit to Singapore’s case
por: Pan, Hanshuang, et al.
Publicado: (2020)

Precision tests of the standard model on the toponium resonance
por: Grzadkowski, Bohdan, et al.
Publicado: (1985)

Betel leaf: Revisiting the benefits of an ancient Indian herb
por: Toprani, Rajendra, et al.
Publicado: (2013)

Prognostic Model to Predict Survival Outcome for Curatively Resected Liposarcoma: A Multi-Institutional Experience
por: Oh, Yoon Jung, et al.
Publicado: (2016)

A framework for quantifying net benefits of alternative prognostic models‡
por: Rapsomaniki, Eleni, et al.
Publicado: (2012)

Breast compression revisited
por: Poulos, AE, et al.
Publicado: (2004)

Breast Screening Revisited
por: Agrawal, Alka, et al.
Publicado: (2014)

A prognostic survival model for women diagnosed with invasive breast cancer in Queensland, Australia
por: Baade, Peter D, et al.
Publicado: (2022)

Cost–benefit model for multi-generational high-technology products to compare sequential innovation strategy with quality strategy
por: Kim, Hyoung Jun, et al.
Publicado: (2021)

Germline contamination and leakage in whole genome somatic single nucleotide variant detection
por: Sendorek, Dorota H., et al.
Publicado: (2018)

Revisiting the vanishing refuge model of diversification
por: Damasceno, Roberta, et al.
Publicado: (2014)

Revisiting speculative hyperinflations in monetary models()
por: Obstfeld, Maurice, et al.
Publicado: (2021)

Revisiting Experimental Models of Diabetic Nephropathy
por: Giralt-López, Anna, et al.
Publicado: (2020)

Pearle’s Hidden-Variable Model Revisited
por: Gill, Richard David
Publicado: (2019)

Revisit Prediction by Deep Survival Analysis
por: Kim, Sundong, et al.
Publicado: (2020)

Revisiting the Syndecans: Master Signaling Regulators with Prognostic and Targetable Therapeutic Values in Breast Carcinoma
por: Motta, Juliana Maria, et al.
Publicado: (2023)

Validation and Recalibration of Two Multivariable Prognostic Models for Survival and Independence in Acute Stroke
por: Sim, Julius, et al.
Publicado: (2016)

A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
por: Haibe-Kains, B., et al.
Publicado: (2008)

Survival benefits of antiretroviral therapy in Brazil: a model-based analysis
por: Luz, Paula M, et al.
Publicado: (2016)

Modelled mortality benefits of multi-cancer early detection screening in England
por: Sasieni, Peter, et al.
Publicado: (2023)

Revisiting rodent models: Octodon degus as Alzheimer’s disease model?
por: Steffen, Johannes, et al.
Publicado: (2016)

Revisiting the Plasmodium falciparum RIFIN family: from comparative genomics to 3D-model prediction
por: Bultrini, Emanuele, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_rpaehtm0baaukrc6b4shfp85om